Lyra Therapeutics raises $29.5M for chronic rhinosinusitis drug implant
The company plans to use the funding to advance LYR-210 into a Phase II clinical trial and also explore its development platform in other ENT diseases.
Vascular Pharmaceuticals announces $9M expansion of Series A financing
The mission to move forward with addressing complications for diabetic patients, specifically diabetic nephropathy that leads to kidney disease, continues Tuesday with an increase in Series A funding (a $9 million addition that brings the total to $25 million) for the clinical-stage pharmaceutical company Vascular Pharmaceuticals, Inc. (VPI). According to a press release, existing investors […]
Medicine in a microchip: Implant holds up to 400 doses, could replace needles
Earlier this summer, we saw the first “smart pill” from Proteus Digital Health receive U.S. Food and Drug Administration clearance, a huge step in connecting drug delivery with mobile technologies. So what comes next? It would be years before we see it on the market, but the next generation of smart medicine just may lie […]
RTP venture capital climate improved in Q1 but biotechs still clamor for cash
Early stage life science companies still developing their technologies can fall into a gap: too expensive to be supported by more grants or angel investments yet not far enough along to secure venture capital interest. In the worst economy in generations, their funding challenges are more pronounced. But the first quarter saw several companies in […]
NC diagnostics device company AAD raises $11M in series B round
Diagnostics firm Advanced Animal Diagnostics has closed an $11 million series B round. The Durham, North Carolina-based company is developing a test for mastitis in dairy cows.